For the quarter ending 2026-03-31, TPST has $10,748K in assets. $9,926K in debts. $1,805K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 1,805 | 7,707 | 7,514 | 14,280 |
| Prepaid expenses and other current assets | 641 | 562 | 590 | 823 |
| Total current assets | 2,446 | 8,269 | 8,104 | 15,103 |
| Property and equipment | 2,058 | 2,058 | 2,203 | - |
| Less accumulated depreciation | 1,513 | 1,453 | 1,522 | - |
| Property and equipment-net | 545 | 605 | 681 | 748 |
| Operating lease right-of-use assets | 7,248 | 7,540 | 7,825 | 8,104 |
| Other noncurrent assets | 509 | 517 | 519 | 529 |
| Total assets | 10,748 | 16,931 | 17,129 | 24,484 |
| Accounts payable | 585 | 1,038 | 922 | 4,716 |
| Accrued expenses | 1,162 | 937 | 1,353 | 1,221 |
| Current loan payable (net of discount and issuance costs of nil and 74, respectively) | - | 0 | 0 | 0 |
| Interest payable | - | 0 | 0 | 0 |
| Current operating lease liabilities | 1,239 | 1,192 | 1,147 | 1,103 |
| Accrued compensation | 325 | 147 | 103 | 101 |
| Total current liabilities | 3,311 | 3,314 | 3,525 | 7,141 |
| Operating lease liabilities, less current portion | 6,615 | 6,949 | 7,258 | 7,560 |
| Total liabilities | 9,926 | 10,263 | 10,783 | 14,701 |
| Common stock, 0.001 par value 100,000,000 shares authorized 14,344,034 and 4,927,161 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 14 | 5 | 4 | 4 |
| Additional paid-in capital | 270,880 | 240,031 | 235,689 | 235,615 |
| Accumulated deficit | -270,072 | -233,368 | -229,347 | -225,836 |
| Total stockholders equity | 822 | 6,668 | 6,346 | 9,783 |
| Total liabilities and stockholders equity | 10,748 | 16,931 | 17,129 | 24,484 |
Tempest Therapeutics, Inc. (TPST)
Tempest Therapeutics, Inc. (TPST)